BIOLINERX
Careers | Contact Us
search

Press Releases
December 16, 2013
Initial results for BL-8040 show substantial mobilization
of cancer cells and signs of robust cancer cell death (apoptosis)
December 10, 2013
BL-8040 is currently in midst of Phase 2 study in AML patients, with partial results expected this month and final results expected in H2 2014
November 26, 2013
New results show BL-7040 to reduce pro-inflammatory cytokine levels and improve colon histology in IBD patients
BL-7040 was previously shown to be safe and effective in Phase 2a trial completed in Q2 2013

November 19, 2013
Results published in Clinical Cancer Research
Additional clinical trial in stem cell mobilization expected to commence in H1 2014

November 6, 2013
Management to hold conference call at 10:00 a.m. EST
November 4, 2013
Study expected to begin by end of 2013
Results expected in mid-2014

October 23, 2013
Preclinical data show that BL-9020 prevents formation of Type 1 diabetes
181-190  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next